Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Ipsen Reports Strong IQIRVO Results in PBC Phase III Study - TipRanks.com
Ipsen Unveils Positive Results for Iqirvo | MarketScreener
Genfit: Iqirvo royalties up 188% over nine months, revenue down
What fracture risk was reported in patients treated with Iqirvo ...
Ipsen (ENXTPA:IPN) Posts Strong IQIRVO Data, Is The Upside Already ...
Ipsen IQIRVO trial: 85.3% normalized ALP at 52 weeks | IPSEY Stock News
Ipsen : des données sur Iqirvo relèvent les ambitions thérapeutiques ...
GENFIT Reports Strong Iqirvo Royalties and MASH Diagnostic Progress ...
Ipsen Pharma: IQIRVO late-breaking data raises ambitions in PBC with ...
IQIRVO - Wa Man (HK) Limited 華民行(香港)有限公司
FDA Approves Iqirvo for Primary Biliary Cholangitis (PBC) – Patient Worthy
Data on Pruritus & Fatigue | IQIRVO Trial Results | Official HCP Site
Iqirvo (Elafibranor Tablets): Side Effects, Uses, Dosage, Interactions ...
Ipsen dévoile des résultats concluants pour Iqirvo | La Tribune de l ...
CBP : IQIRVO normalise les PAL chez 85,3 % des patients à 52 semaines ...
GENFIT to receive $20M milestone from Ipsen as Iqirvo tops $200M in ...
Ipsen Reports Positive Phase IIIb Results for IQIRVO in PBC - Pharmacally
Iqirvo Tablet, Film Coated - NDC 15054-0080-1
Ipsen : Iqirvo normalise la PAL chez 85,3 % des patients en phase III ...
NICE (UK) positive for Iqirvo (elafibranor) for previously treated ...
Iqirvo Shows Significant Fatigue Improvement in Patients with Primary ...
ELATIVE: Iqirvo ‘effective, well-tolerated treatment option’ for ...
FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC FDA OKs Iqirvo ...
Late breaking data for Iqirvo (elafibranor) from interim analysis of ...
NICE recommends Ipsen’s Iqirvo for PBC, a rare liver disease ...
Noccela and Qorvo at CES 2024 in Las Vegas | Noccela
IQIRVO® late-breaking data raises ambitions in PBC with more than 85% ...
The Skyworks–Qorvo Merger Fixed Scale. The First Report Showed It Didn ...
Qorvo stock gives way to Skyworks after merger completion
Qorvo (NASDAQ:QRVO) vs. Micron Technology (NASDAQ:MU) Financial Survey ...
DKFC5071A datasheet(20/27 Pages) QORVO | WIDEBAND SYNTHESIZER/VCO WITH ...
Qorvo Launches AI-Powered Virtual FAE for Engineering Design Support ...
Skyworks Leads Market in Turnover as Investors Clash Over Qorvo ...
TGA2239-CPEVB datasheet(9/15 Pages) QORVO | 13.4 ??15.5 GHz 50 W GaN ...
Skyworks Q4 FY2026 Earnings Call: Qorvo Integration and $500M-Plus ...
Skyworks Solutions Inc (SWKS) (Q4 2026) Earnings Call Highlights: Qorvo ...
Qorvo (QRVO) Stock Looks Richer Than Its Cash Flow Outlook
Skyworks Solutions Q4 2026: Qorvo deal reshapes the story | 24/7 Wall St.
QPA2575 Qorvo, part of Skyworks RF Amplifier|RFMW
Ipsen Announces Late-Breaking Data From ELSPIRE Phase III Study of ...
AASLD 2026 Update 5: Ipsen Iqirvo, Resolution Rtx001 - YouTube
Skyworks Completes Acquisition of Qorvo | PrivSource
TGA2218-SM Qorvo, part of Skyworks RF Amplifier|RFMW
Qorvo RF Development Tools – Mouser United Kingdom
SpaceX Stock Falls Despite Major Qualcomm 5G Deal
Skyworks completes Qorvo merger, reports Q4 revenue of $1.05B By ...
TGM2543-SM Qorvo | Mouser
Markets & Stocks - GENFIT Reports Third Quarter 2026 Financial ...
Film Bulk Acoustic Resonator Filters Market, 2025–2035 | Broadcom ...
QPA0015EVB Qorvo, part of Skyworks RF Evaluation Board|Qorvo
Les données «late-breaking» sur IQIRVO® relèvent les ambitions ...
Skyworks completes Qorvo deal, expects $500m in cost synergies
Head of Marketing (Temp) at Ipsen Biopharmaceuticals Inc. – Cambridge ...
Starboard Value Sees Potential Upside in Skyworks Following Qorvo ...
Very slow bode plot with c++ block - QSPICE - Qorvo Tech Forum
[Skyworks Solutions Q4 2026 Earnings Call] Skyworks Guides Combined ...
TGS2353-2-SM control states - RF All Other (switches, controls ...
دراسة طبية تؤكد فعالية عقار إيكيرفو في تحسين وظائف الكبد لمرضى التهاب ...
Starboard sees big upside in Skyworks after Qorvo merger, Bloomberg ...
GENFIT Reports Third Quarter 2026 Financial Information and Provides ...
RFCA8828SR from Qorvo
Health rounds: New blood test matches gold standard for liver disease ...
Reg. Compliance Analyst at Blackhawk Network - Financial Jobs
Skyworks Stock Sinks as Android Woes Delay the Qorvo's Merger Payoff
Qorvo - No Work-Life Flexibility | Glassdoor
IQIRVO® (elafibranor) | Official Patient Site
PBC treatment | IQIRVO® (elafibranor) Patient Testimonials
Homepage - Genfit
Skyworks issues $778M and $647M in Qorvo note exchange | SWKS 8-K Filing
Customer Quality Engineering Intern Job Details | Qorvo @ Qorvo, Inc ...
思佳讯2026财年第四季度业绩电话会议：Qorvo整合及超5亿美元协同效应计划
What Qorvo Stock Removal From Russell Indices Means For Shareholders ...
IQIRVO: First-And-Only PPAR Alpha + Delta Activation Treatment ...
Starboard ve potencial en Skyworks tras compra de Qorvo y apunta a ...
Qorvo Color Codes - Hex, RGB and CMYK Color Codes
GENFIT Celebrates EU Approval of Iqirvo® for Liver Disease Treatment ...
Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy ...
IQIRVO: A Revolutionary PPAR Agonist Transforms Second-Line Treatment ...
Iqirvo: Uses, Side Effects, Dosage, Cost, and More
New FDA Approval: Iqirvo® (elafibranor)
Genfit chute en Bourse sous l'effet de prises de bénéfices, la ...
Ipsen's Iqirvo® Gains Fast-Track FDA Approval for Primary Biliary ...
Iqirvo: A New Treatment for Primary Biliary Cholangitis - ScienceMyHealth
Qorvo adds compact X-band radar front end | IN Electronics & Design
Iqirvo® (elafibranor) - Singapore
Semiconductor company Qorvo reports $48 million operating loss in Q1 ...
Qorvo (NASDAQ: QRVO) is focusing its Oregon facility on future designs ...
Kris Kowdley, MD, Presents Positive Late-Breaking Data for Ipsen’s ...
New safety updates on Nexavar®-Iqirvo®-Nitric oxide, Treprostinil ...
Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approval ...
Chipmaker Qorvo will move some manufacturing to Oregon from North ...
